Ani Pharmaceuticals (ANIP) Other Accumulated Expenses (2010 - 2026)
Ani Pharmaceuticals' Other Accumulated Expenses came in at $55.83 million for Q2 2026, up 55.0% from $36.03 million a year earlier and up 64.6% from the prior quarter.
Ani Pharmaceuticals (ANIP) Other Accumulated Expenses (2010 - 2026) Analysis & Trends
At the end of FY2025, Ani Pharmaceuticals' Other Accumulated Expenses was $48.5 million, up 114.3% from FY2024.
- Other Accumulated Expenses has increased in each of the last four years, with a five-year compound annual growth rate of 49.9% (FY2020 to FY2025).
- Going back by year, Other Accumulated Expenses was $22.63 million in FY2024 (+39.0%), $16.28 million in FY2023 (+74.9%), $9.31 million in FY2022 (+49.5%) and $6.23 million in FY2021 (-2.8%).
- The Q2 2026 figure represents the highest quarterly Other Accumulated Expenses in data going back to Q4 2010.
- Year-over-year, Other Accumulated Expenses has increased for 17 consecutive quarters, with growth averaging 74.5% over the last eight quarters.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in Q3 2025 (growth of 118.6%), and the weakest in Q3 2021 (a decline of 34.4%).
- Business Quant data shows ANIP's Other Accumulated Expenses at $33.93 million (Q1 2026), $48.5 million (Q4 2025) and $51.25 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Ani Pharmaceuticals | 1.72 Bn | 502.13 Mn | 165.89 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 55.83 Mn |
| Mar 31, 2026 | 33.93 Mn |
| Dec 31, 2025 | 48.50 Mn |
| Sep 30, 2025 | 51.25 Mn |
| Jun 30, 2025 | 36.03 Mn |
| Mar 31, 2025 | 23.71 Mn |
| Dec 31, 2024 | 22.63 Mn |
| Sep 30, 2024 | 23.45 Mn |
| Jun 30, 2024 | 20.36 Mn |
| Mar 31, 2024 | 15.48 Mn |
| Dec 31, 2023 | 16.28 Mn |
| Sep 30, 2023 | 11.98 Mn |
| Jun 30, 2023 | 9.89 Mn |
| Mar 31, 2023 | 8.96 Mn |
| Dec 31, 2022 | 9.31 Mn |
| Sep 30, 2022 | 6.59 Mn |
| Jun 30, 2022 | 6.30 Mn |
| Mar 31, 2022 | 5.00 Mn |
| Dec 31, 2021 | 6.23 Mn |
| Sep 30, 2021 | 4.00 Mn |
Ani Pharmaceuticals Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ANIP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "ANIP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ANIP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();